Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Harrison

Showing results (91-100 of 583) with videos related to

Pageof 59
Sort By:
Future Oncology (London, England)|January 24, 2020
Current and future role of fedratinib in the treatment of myelofibrosisMonica Ragheb, Claire N Harrison, Donal P McLornan
Biologics : Targets & Therapy|August 31, 2013
Treatment and management of myelofibrosis in the era of JAK inhibitorsClodagh Keohane, Deepti H Radia, Claire N Harrison
Bioorganic & Medicinal Chemistry Letters|December 30, 2011
Synthesis and evaluation of tetrahedral intermediate mimic inhibitors of 3-deoxy-d-manno-octulosonate 8-phosphate synthaseAidan N Harrison, Sebastian Reichau, Emily J Parker
Journal of Psychiatric and Mental Health Nursing|June 23, 2009
An educational evaluation of supervisor and mentor experiences when supporting primary care graduate mental health workersN Harrison, C Lyons, C Baguley, et al.
Journal of Receptor Research|January 1, 1993
Chronic antagonist treatment does not alter the mode of interaction of dopamine with rat striatal dopamine receptorsK M O'Boyle, K T Gavin, N Harrison
NMR in Biomedicine|February 1, 1995
A 31P NMR investigation into the effects of repeated vascular occlusion on uterine metabolites, intracellular pH and force, in vivoN Harrison, J B Larcombe-McDouall, S Wray
Leukemia & Lymphoma|March 26, 2002
Hydroxyurea-associated platelet count oscillations in polycythemia vera: a report of four new cases and a reviewD P Steensma, C N Harrison, A Tefferi
Clinical Pediatrics|March 13, 2023
Behavioral Concerns in Early Childhood Consultation: Diagnostic Overshadowing and ComorbidityMary L Leppert, Amie Bettencourt, Joyce N Harrison
Therapeutics and Clinical Risk Management|October 16, 2020
Evaluating the Safety, Efficacy, and Therapeutic Potential of Momelotinib in the Treatment of Intermediate/High-Risk Myelofibrosis: Evidence to DateSarah Bassiony, Claire N Harrison, Donal P McLornan
Anaesthesia|March 1, 1992
Appropriate use of local anaesthetic for venous cannulationN Harrison, B T Langham, D G Bogod
Pageof 59

Showing results (91-100 of 583) with videos related to

Sort By:
Pageof 59
Future Oncology (London, England)|January 24, 2020
Current and future role of fedratinib in the treatment of myelofibrosisMonica Ragheb, Claire N Harrison, Donal P McLornan
Biologics : Targets & Therapy|August 31, 2013
Treatment and management of myelofibrosis in the era of JAK inhibitorsClodagh Keohane, Deepti H Radia, Claire N Harrison
Bioorganic & Medicinal Chemistry Letters|December 30, 2011
Synthesis and evaluation of tetrahedral intermediate mimic inhibitors of 3-deoxy-d-manno-octulosonate 8-phosphate synthaseAidan N Harrison, Sebastian Reichau, Emily J Parker
Journal of Psychiatric and Mental Health Nursing|June 23, 2009
An educational evaluation of supervisor and mentor experiences when supporting primary care graduate mental health workersN Harrison, C Lyons, C Baguley, et al.
Journal of Receptor Research|January 1, 1993
Chronic antagonist treatment does not alter the mode of interaction of dopamine with rat striatal dopamine receptorsK M O'Boyle, K T Gavin, N Harrison
NMR in Biomedicine|February 1, 1995
A 31P NMR investigation into the effects of repeated vascular occlusion on uterine metabolites, intracellular pH and force, in vivoN Harrison, J B Larcombe-McDouall, S Wray
Leukemia & Lymphoma|March 26, 2002
Hydroxyurea-associated platelet count oscillations in polycythemia vera: a report of four new cases and a reviewD P Steensma, C N Harrison, A Tefferi
Clinical Pediatrics|March 13, 2023
Behavioral Concerns in Early Childhood Consultation: Diagnostic Overshadowing and ComorbidityMary L Leppert, Amie Bettencourt, Joyce N Harrison
Therapeutics and Clinical Risk Management|October 16, 2020
Evaluating the Safety, Efficacy, and Therapeutic Potential of Momelotinib in the Treatment of Intermediate/High-Risk Myelofibrosis: Evidence to DateSarah Bassiony, Claire N Harrison, Donal P McLornan
Anaesthesia|March 1, 1992
Appropriate use of local anaesthetic for venous cannulationN Harrison, B T Langham, D G Bogod
Pageof 59